| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | yst |
| Uniprot No | P31518 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 51-66aa |
| 氨基酸序列 | SDWCCEVCCNPACAGC |
| 预测分子量 | 17.1 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于YST重组蛋白的3篇虚构参考文献示例，供参考：
---
1. **文献名称**：Optimized Expression of YST Recombinant Protein in Pichia pastoris
**作者**：Zhang L., et al.
**摘要**：本研究通过优化毕赤酵母表达系统中的启动子、诱导条件和培养基成分，显著提高了YST重组蛋白的分泌表达效率，为大规模生产奠定了基础。
2. **文献名称**：Purification and Functional Analysis of YST Recombinant Protein for Immunotherapy
**作者**：Wang Q., et al.
**摘要**：报道了一种基于镍柱亲和层析的高效纯化工艺，验证了YST蛋白在体外可激活T细胞免疫应答，提示其在肿瘤免疫治疗中的潜在应用。
3. **文献名称**：Structural Characterization of YST Recombinant Protein by Cryo-EM
**作者**：Liu X., et al.
**摘要**：利用冷冻电镜技术解析了YST重组蛋白的三维结构，揭示了其与配体结合的关键位点，为靶向药物设计提供了结构依据。
---
注：以上文献为示例性内容，实际研究中请根据具体研究方向检索真实文献。
**Background of YST Recombinant Protein**
YST recombinant protein is a bioengineered molecule designed for diverse therapeutic, diagnostic, and research applications. The term "YST" may refer to a specific protein variant or a proprietary designation linked to its origin, structure, or function. Recombinant proteins like YST are typically produced using genetic engineering techniques, where target genes are cloned into expression systems (e.g., bacteria, yeast, or mammalian cells) to enable large-scale, high-purity production.
YST is likely derived from a natural protein modified to enhance stability, solubility, or functional efficacy. Such proteins often serve as critical tools in biologics development, including vaccines, monoclonal antibodies, or enzyme replacements. For instance, if YST is cytokine- or antibody-based, it may target specific immune pathways or disease biomarkers. Its design might incorporate tags (e.g., His-tags) for simplified purification or tracking during experiments.
The development of YST aligns with advancements in precision medicine and biopharmaceuticals, where tailored proteins address unmet clinical needs. Its applications could span cancer therapy, autoimmune disease management, or infectious disease diagnostics. Researchers might utilize YST to study protein-protein interactions, cellular signaling, or as a reference standard in assays.
A key advantage of recombinant proteins like YST lies in their reproducibility and scalability, overcoming limitations of traditional protein extraction methods. Additionally, engineered modifications reduce immunogenicity and improve pharmacokinetics, making them suitable for therapeutic use.
While specific details on YST's proprietary background may be limited, its framework reflects broader trends in biotechnology: leveraging synthetic biology and computational modeling to optimize protein function. Ongoing research likely focuses on validating its efficacy in preclinical models and refining production pipelines for clinical translation.
In summary, YST recombinant protein exemplifies the intersection of molecular biology and industrial biotechnology, aiming to deliver innovative solutions across healthcare and scientific research.
×
